Hepatitis B virus infection and risk of non‐alcoholic fatty liver disease: A population‐based cohort study
Liguo Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Yan Zhou(Soochow University), Xiaozhong Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Jiang(Qilu Hospital of Shandong University), Dong Hang(Nanjing Health and Health Commission), Aileen Baecker(Los Angeles County Department of Public Health), Ci Song(Yanbian University), Zhibin Hu(Nanjing Medical University), Zuo‐Feng Zhang(University of California, Los Angeles), Hongjian Liu(First Affiliated Hospital of Zhengzhou University), Jianfang Xu(Fudan University), Xiangjun Zhai(Jiangsu Provincial Center for Disease Control and Prevention), Minghao Zhou(Jiangsu Provincial Center for Disease Control and Prevention), Hongbing Shen(Jiangsu Cancer Hospital)
Cited by 60
Related Papers
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
|Nature Biotechnology|2002|2.5k
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
|eLife|2012|2.1k
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k